| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Revenue | $676.8M | +15.9% |
| R&D Expense | $1.0M | -16.7% |
| SG&A Expense | $149.9M | +2.2% |
| Operating Income | -$95.7M | +21.8% |
| Interest Expense | $256K | +100.0% |
| Pre-tax Income | -$91.7M | +18.9% |
| Income Tax | -$1.3M | -443.3% |
| Net Income | -$90.4M | +20.3% |
| EPS (Basic) | -$0.79 |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $214.8M | -16.5% |
| Accounts Receivable | $5.0M | +43.7% |
| Inventory | $2.0M | -4.0% |
| Current Assets | $234.5M | -15.1% |
| Total Assets | $856.8M | +0.0% |
| Current Liabilities | $115.8M | +26.5% |
| Total Liabilities | $410.6M | +9.8% |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $43.4M | +63.9% |
| Capital Expenditures | $84.5M | -5.8% |
| Investing Cash Flow | -$92.2M | +3.6% |
| Financing Cash Flow | $8.9M | +271.1% |
| Free Cash Flow | -$41.1M | +35.0% |
| +21.8% |
| EPS (Diluted) | -$0.79 | +21.8% |
| Stockholders' Equity |
| $446.1M |
| -7.6% |